Josef Scheiber

1.8k citations

33 papers · 1.4k indexed · h-index 17

Impact in

Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods
Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Cholinesterase and Neurodegenerative Diseases
- Microbial Natural Products and Biosynthesis

Papers in ⓘ

Computational Theory and Mathematics 16
- Computational Drug Discovery Methods 16
Molecular Biology 15
- Chemical Synthesis and Analysis 3
- Metabolomics and Mass Spectrometry Studies 3

Co-authors: Andreas Bender (11 shared papers)Jeremy L. Jenkins (11 shared papers)Meir Glick (10 shared papers)John W. Davies (9 shared papers)Sai Chetan K. Sukuru (6 shared papers)Ulrike Holzgrabe (4 shared papers)Steven Whitebread (5 shared papers)László Urbán (5 shared papers)
Journals: Journal of Chemical Information and Modeling (4 papers)ChemMedChem (3 papers)European Journal of Organic Chemistry (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Josef Scheiber

31 papers receiving 1.4k citations

Peers

Countries citing papers authored by Josef Scheiber

Since Specialization

Citations

This map shows the geographic impact of Josef Scheiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Scheiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Scheiber more than expected).

Fields of papers citing papers by Josef Scheiber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Scheiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Scheiber. The network helps show where Josef Scheiber may publish in the future.

Co-authors

The 25 scholars most cited alongside Josef Scheiber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Josef Scheiber Line = papers co-authored together Josef Scheiber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure ChemMedChem ·Andreas Bender, Josef Scheiber, Meir Glick, John W. Davies, Khalil Azzaoui, Jacques Hamon, László Urbán, Steven Whitebread, Jeremy L. Jenkins	2007	247
2	How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space Journal of Chemical Information and Modeling ·Andreas Bender, Jeremy L. Jenkins, Josef Scheiber, Sai Chetan K. Sukuru, Meir Glick, John W. Davies	2009	229
3	Targeting acetylcholinesterase to treat neurodegeneration Expert Opinion on Therapeutic Targets ·Ulrike Holzgrabe, Petra Kapková, Vildan Alptüzün, Josef Scheiber, Eva Kugelmann	2007	182
4	Mapping Adverse Drug Reactions in Chemical Space Journal of Medicinal Chemistry ·Josef Scheiber, Jeremy L. Jenkins, Sai Chetan K. Sukuru, Andreas Bender, Д. А. Михайлов, Mariusz Milik, Khalil Azzaoui, Steven Whitebread, Jacques Hamon, László Urbán, Meir Glick, John W. Davies	2009	125
5	Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis Journal of Chemical Information and Modeling ·Josef Scheiber, Bin Chen, Mariusz Milik, Sai Chetan K. Sukuru, Andreas Bender, Д. А. Михайлов, Steven Whitebread, Jacques Hamon, Khalil Azzaoui, László Urbán, Meir Glick, John W. Davies, Jeremy L. Jenkins	2009	124
6	Plate-Based Diversity Selection Based on Empirical HTS Data to Enhance the Number of Hits and Their Chemical Diversity SLAS DISCOVERY ·Sai Chetan K. Sukuru, Jeremy L. Jenkins, Rohan E. J. Beckwith, Josef Scheiber, Andreas Bender, Д. А. Михайлов, John W. Davies, Meir Glick	2009	58
7	Aziridide‐Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies ChemMedChem ·Radim Vičík, Matthias Busemann, Christoph Gelhaus, Nikolaus Stiefl, Josef Scheiber, Werner Schmitz, F. A. Schulz, Milena Mladenović, Bernd Engels, Matthias Leippe, Knut Baumann, Tanja Schirmeister	2006	54
8	Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data Journal of Chemical Information and Modeling ·Thomas J. Crisman, Christian N. Parker, Jeremy L. Jenkins, Josef Scheiber, Mathis Thoma, Kang Zhao, Richard Kim, Andreas Bender, James H. Nettles, John W. Davies, Meir Glick	2007	51
9	Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with β-amyloid, acetylcholine, and butyrylcholine esterases Bioorganic & Medicinal Chemistry ·Vildan Alptüzün, Michaela Prinz, Verena Hörr, Josef Scheiber, Krzysztof Radacki, Adyary Fallarero, Pia Vuorela, Bernd Engels, Holger Braunschweig, Erçin Erciyas, Ulrike Holzgrabe	2010	39
10	Charge Interactions Do the Job: A Combined Statistical and Combinatorial Approach to Finding Artificial Receptors for Binding Tetrapeptides in Water Angewandte Chemie International Edition ·Carsten Schmuck, Martin Heil, Josef Scheiber, Knut Baumann	2005	37
11	NMR Spectroscopic and Molecular Modelling Studies on Cyclodextrin–Dipeptide Inclusion Complexes European Journal of Organic Chemistry ·Claudia Kahle, Ralph Deubner, Curd Schollmayer, Josef Scheiber, Knut Baumann, Ulrike Holzgrabe	2005	36
12	Which aspects of HTS are empirically correlated with downstream success? PubMed ·Andreas Bender, Dejan Bojanic, John Davies, Thomas J. Crisman, Д. А. Михайлов, Josef Scheiber, Jeremy L. Jenkins, Zhan Deng, William A. Hill, Maxim Popov, Edgar Jacoby, Meir Glick	2008	34
13	Comparison of Cyclodextrin‐Dipeptide Inclusion Complexes in the Absence and Presence of Urea by Means of Capillary Electrophoresis, Nuclear Magnetic Resonance and Molecular Modeling European Journal of Organic Chemistry ·Benjamin Waibel, Josef Scheiber, Claudia Meier, Manuela Hammitzsch, Knut Baumann, Gerhard K. E. Scriba, Ulrike Holzgrabe	2007	33
14	“Virtual Fragment Linking”: An Approach To Identify Potent Binders from Low Affinity Fragment Hits Journal of Medicinal Chemistry ·Thomas J. Crisman, Andreas Bender, Mariusz Milik, Jeremy L. Jenkins, Josef Scheiber, Sai Chetan K. Sukuru, Jasna Fejzo, Ulrich Hommel, John W. Davies, Meir Glick	2008	30
15	Side effect profile prediction - early addressing of big pharma's worst nightmare Chemistry Central Journal ·Josef Scheiber, James L. Jenkins, Andreas Bender, Steven Whitebread, Jacques Hamon, László Urbán, Khalil Azzaoui, Michael Glick, J. Davies	2008	27
16	Cis‐Configured Aziridines Are New Pseudo‐Irreversible Dual‐Mode Inhibitors of Candida albicans Secreted Aspartic Protease 2 ChemMedChem ·Björn Degel, Peter Staib, Sebastian Rohrer, Josef Scheiber, Erika Martina, Christian Büchold, Knut Baumann, Joachim Morschhäuser, Tanja Schirmeister	2007	18
17	Use of Ligand Based Models for Protein Domains To Predict Novel Molecular Targets and Applications To Triage Affinity Chromatography Data Journal of Proteome Research ·Andreas Bender, Д. А. Михайлов, Meir Glick, Josef Scheiber, John W. Davies, Stephen H. Cleaver, Stephen Marshall, John A. Tallarico, Edmund Harrington, Iván Cornella‐Taracido, Jeremy L. Jenkins	2009	17
18	Ladungswechselwirkungen machen es möglich: ein kombinierter statistischer und kombinatorischer Ansatz zur Auffindung künstlicher Rezeptoren für die Bindung von Tetrapeptiden in Wasser Angewandte Chemie ·Carsten Schmuck, Martin Heil, Josef Scheiber, Knut Baumann	2005	14
19	SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy Cancer Medicine ·Louisa Hempel, Armin P. Piehler, Michael W. Pfaffl, Jakob Molnar, Benedikt Kirchner, Sebastian Robert, Julia Veloso, Beate Gandorfer, Željka Trepotec, Stefanie Mederle, Sabine Keim, Valeria Milani, Florian Ebner, Katrin Schweneker, Bastian Fleischmann, Axel Kleespies, Josef Scheiber, Dirk Hempel, Dietmar Zehn	2020	12
20	xMaP—An Interpretable Alignment-Free Four-Dimensional Quantitative Structure–Activity Relationship Technique Based on Molecular Surface Properties and Conformer Ensembles Journal of Chemical Information and Modeling ·Jan Dreher, Josef Scheiber, Nikolaus Stiefl, Knut Baumann	2017	11

About Josef Scheiber

Josef Scheiber is a scholar working on Computational Theory and Mathematics, Molecular Biology, Spectroscopy, Pharmacology and Organic Chemistry, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (16 papers), Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Chemical Synthesis and Analysis (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Cell Image Analysis Techniques (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Computational Theory and Mathematics (877 citations), Pharmacology (220 citations), Toxicology (73 citations), Pharmacology (357 citations) and Molecular Biology (756 citations). Josef Scheiber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Andreas Bender, Jeremy L. Jenkins, Meir Glick, John W. Davies, Sai Chetan K. Sukuru, Ulrike Holzgrabe, Steven Whitebread, László Urbán, Khalil Azzaoui and Jacques Hamon. Their work appears in journals such as Journal of Chemical Information and Modeling, ChemMedChem, European Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact